Patients with a high expression had poor survival when compared to those with a low expression (p = 0.0136) (Figure 5B), suggesting that hsa-miR-940 may negatively impact breast cancer survival, an effect opposite to that of ZNF582-AS1. The gene discussed is ZNF582; the disease is breast carcinoma.